Daily Archive: October 1, 2015

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

Overview This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches. Authors: WHO